CHICAGO: Surgeons can play a key role in reducing breast cancer disparities by increasing their awareness of where disparities exist and having open conversations with their patients about their needs to initiate referrals early on in their care, according to a new collective review article published in the Journal of the American College of Surgeons (JACS).
Despite improved screening and treatment options for breast cancer — the most common cancer diagnosed in women excluding skin cancers — many populations face significant barriers to screening and treatment options for breast cancer.
Following a well-received in-person panel discussion on breast cancer disparities held at the American College of Surgeons (ACS) Clinical Congress in October 2022, an interdisciplinary team of clinicians, which included surgeons, a radiologist, and public health researchers, convened to explore these disparities in more detail for a research article in JACS.
“Many breast surgeons may already be aware of some of the disparities that exist in regard to breast cancer care, but we wanted to illustrate the wide scope of the problems and raise awareness among general surgeons and other healthcare providers who treat breast cancer patients,” said Kathie-Ann Joseph, MD, MPH, FACS, senior author of the study and a professor of surgery and population health at New York University (NYU) Langone Health. “Whether you work in a rural or city hospital, these are real issues that we deal with and face every day.”
Areas of Disparity
While disparities are multifactorial, the researchers identified four specific areas where disparities remain concerning: screening, genetic testing, reconstruction, and access to fertility-preservation treatments for cancer patients (also known as oncofertility).
“These are topics that are often overlooked. We sort of assume that most women who are diagnosed with breast cancer may require these services and that they are readily available. But unfortunately, depending on geography or the type of hospital that a patient is being treated, many of these services may not be available,” explained Dr. Joseph, who also serves as vice-chair for diversity and health equity at NYU Langone Health. “Or if they are available, certain patients may not have the full breadth of access for some of these services or treatments.”
- Variable access to screening: Many women may not have access to or be able to afford some of the latest screening technologies — including 3D mammography, breast ultrasound, and breast magnetic resonance imaging (MRI) — even with health insurance. These technologies are increasingly used to screen for breast cancer and monitor women at high risk of the disease and/or who have increased breast density. The pandemic has further exacerbated these challenges by delaying screening for some women.
“There are differences in what screening services are offered, so I think we need to be asking: How do we make sure that people have equal access to the latest technologies so that they can anticipate the same great outcomes that other women can have?,” said Angelena Crown, MD, FACS, first author of the study and a breast surgeon at Swedish Cancer Institute in Seattle, Washington. “If we can find more cancers at an earlier stage, then we can really start seeing improvements, not only in survival but also in the quality of life associated with the treatments that are required for more advanced breast cancers.”
- Genetic counseling and testing: Cancer care that integrates knowledge of genetics remains critical for the health of patients with cancer and their families. However, most genes associated with an increased breast cancer risk were first identified in Northern European Whites. As a result, women from different racial and ethnic groups who undergo genetic testing are more likely to receive inconclusive results, also known as variants of uncertain significance (VUS).
“I think there is a need for patient and clinician education about the importance of genetic testing for breast cancer prevention, screening, and targeted therapies,” said Allison Kurian, MD, MSc, a study co-author and professor of medicine and population health at Stanford Medicine. “It is also important for surgeons to recognize the unequal burden of VUS results. Surgeons should be ready to explain the implications of VUS results to patients and refer them to additional genetic counseling when appropriate.”
- Access to fertility preservation: A growing number of women of childbearing age (< age 45) are diagnosed with breast cancer, accounting for about 11% of the population of breast cancer patients.* For these women, fertility preservation is vital for family planning purposes but can be cost-prohibitive for a large majority of patients.
“It’s really important for providers to think about the quality of life that these women are going to have. Most of these women are going to be diagnosed with curable disease, meaning anything less than stage 4, and they are expected to have long, healthy lives,” Dr. Crown said.
- Reconstruction surgery: Patients who undergo a mastectomy have several options for reconstruction, including implant reconstruction or tissue (flap) reconstruction, where a woman’s own tissue from other parts of her body is used to reconstruct the breast. However, even with laws requiring some states to cover reconstruction, insurance and geography may still dictate what kind of reconstruction a patient is likely to receive.
“Oftentimes, having a tissue-based reconstruction is ideal for many patients but that may not be feasible, depending on the type of training the plastic surgeon has, and the availability of the procedure at a specific hospital,” Dr. Joseph explained. Language and health literacy barriers can further impact the information available to a patient.
Strategies to Improve Care
Recognizing the magnitude of these disparities, the researchers outlined key steps that breast cancer centers and surgeons can take to improve equitable care:
- Advocate for patient navigation programs, which can improve rates of screening and increase patient satisfaction.
- Open treatment centers in underserved communities, and when possible, implement flexible hours and help patients with access to travel and childcare assistance.
- Assist with community-led health efforts and produce educational materials in a variety of formats and languages.
- Improve the representation of minority groups in clinical trial research and improve diversity within the oncology workforce through dedicated programming and mentorship opportunities.
- Increase funding of safety-net hospitals, which often treat a large proportion of low-income, uninsured, and other vulnerable populations, and increase research dedicated to addressing health disparities.
- Refer patients, independent of their insurance status, to resources, such as grants or charitable programs, that can assist with coverage for genetic screening and fertility preservation, when possible.
- Integrate genetic testing into oncology care by employing a genetic counselor in oncology clinics and/or offering online counseling and testing protocol, which may extend access to patients in rural areas or to those who have limited access to transportation and/or time off from work.
Unique Role of Surgeons
Surgeons are often the first point of contact in a patient’s journey through breast cancer. Surgeons can be important drivers of change, the authors noted, by maintaining their awareness of existing disparities and providing additional resources to patients when possible.
“One way to make a difference today is to be aware that access to breast cancer services is sub-optimal in many places, and that if you help your individual patients get access to necessary screening or treatment, you are already doing something good,” Dr. Crown said. “By initiating conversations early, surgeons can actually expedite patient care and give patients access to more options. We can really shape what that future life looks like for patients starting right there on day one in the office.”
“Finding small ways to help address disparities, even if it’s just referring a patient for one program that they would not have known about before, can make a huge difference for all our patients who are diagnosed with breast cancer,” Dr. Joseph added. “It just starts with that one small step. There is hope, but it requires work.”
Study coauthors are Soudabeh Fazeli, MD, MPH and Daniela A. Ochoa, MD, FACS.
The study authors have no relevant disclosures to report.
This article is published as an article in press on the JACS website.
Citation: Crown A, Fazeli S, Kurian A, et al. Disparities in Breast Cancer Care: Current State of Access to Screening, Genetic Testing, Oncofertility, and Reconstruction. Journal of American College of Surgeons. DOI: 10.1097/XCS.0000000000000647.
-----
* Trivers KF, Fink AK, Partridge AH, et al. “Estimates of young breast cancer survivors at risk for infertility in the US.” The oncologist 19, no. 8 (2014): 814-822.
